Intralesional Delivery of Dendritic Cells Engineered to Express T-bet Promotes Protective Type 1 Immunity and the Normalization of the Tumor Microenvironment-Reference-Cited by-同舟云学术

Intralesional Delivery of Dendritic Cells Engineered to Express T-bet Promotes Protective Type 1 Immunity and the Normalization of the Tumor Microenvironment

Published:2010-07-30 Issue:5 Volume:185 Page:2895-2902
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Qu Yanyan,Chen Lu,Pardee Angela D.,Taylor Jennifer L.,Wesa Amy K.,Storkus Walter J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro

2. Immunobiology of Dendritic Cells

3. Dendritic Cells in Cancer Immunotherapy

4. Dendritic cells: unique leukocyte populations which control the primary immune response.;Hart;Blood,1997

5. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.;Tatsumi;Cancer Res.,2003

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma;Cancer Immunology, Immunotherapy;2019-05-28

2. Role and Therapeutic Implications of MDSCs in Sarcomas;Immunotherapy of Sarcoma;2018-11-28

3. Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity;OncoImmunology;2017-05-19

4. Intratumoral Approaches for the Treatment of Melanoma;The Cancer Journal;2017-01

5. Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses;OncoImmunology;2016-03-23